Scilex Holding(SCLX) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

12 Health Care Stocks Moving In Wednesday's After-Market Session
BenzingaJun 11 17:05 ET
Scilex Holding Announces Publication On GLOPERBA Dosing Adjustments In Peer-Review Journal
BenzingaJun 5 12:10 ET
Scilex Holding Presents Post-Hoc Analysis of C.L.E.A.R. Trial On Clinical Meaningfulness Of Safety And Efficacy Of SP-102 For Treatment of Lumbosacral Radicular Pain at ASIPP 2025
BenzingaMay 16 09:21 ET
Scilex Holding Company Presented Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of...
GlobeNewswireMay 16 09:00 ET
10-Q: Q1 2025 Earnings Report
SECMay 14 16:33 ET · Announcements
Trump's Drug Price Cuts: Will They Work?
Moomoo News GlobalMay 12 09:35 ET

Comments

Trytosaveabit

Jun 6 00:19

Update

$Scilex Holding (SCLX.US)$ Scilex Holding Announces Publication On GLOPERBA Dosing Adjustments In Peer-Review Journal
Benzinga
5 mins ago
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced a publication on GLOPERBA dosing adjustments in peer-...

Trytosaveabit

May 16 21:25

update

$Scilex Holding (SCLX.US)$ Scilex Holding Presents Post-Hoc Analysis of C.L.E.A.R. Trial On Clinical Meaningfulness Of Safety And Efficacy Of SP-102 For Treatment of Lumbosacral Radicular Pain at ASIPP 2025
Benzinga· 3 mins ago
Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and card...

2

Jaguar8

May 1 02:11

NEWS

$Scilex Holding (SCLX.US)$
Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule
Wednesday, 30th April at 1:46 pm
PALO ALTO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ: SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced th...

Jaguar8

Apr 22 21:00

NEWS

$Scilex Holding (SCLX.US)$
Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 2025 to May 2, 2025
Tuesday, 22nd April at 9:00 am
PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ: SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acqu...

2